Revista de farmacocinética y terapéutica experimental

Abstracto

Phase I run with a unique Altered amide matter Derived from Human Heat-Shock macromolecule sixty for Treatment of arthritic Arthritis: Safety, materia medica and Preliminary Therapeutic Effects

Maria del Carmen Domínguez

CIGB 814 is partner Altered amide count (APL) from a CD4+ T-mobile epitope of human warmth shock macromolecule sixty (HSP60), partner vehicle-antigen worried in the pathological method of autoimmune disease (RA). It iatrogenic mechanisms associated with healing of peripheral tolerance in diagnosing research. This run changed into conducted to assess protection and materia medica (PK) of CIGB-814 in sufferers with RA.